These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 24719069)

  • 1. Finasteride associated melasma in a Caucasian male.
    Famenini S; Gharavi NM; Beynet DP
    J Drugs Dermatol; 2014 Apr; 13(4):484-6. PubMed ID: 24719069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic hotline. Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
    Lynn R; Krunic A
    Dermatol Ther; 2010; 23(5):544-6. PubMed ID: 20868409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible myopathy and ophthalmoparesis after low-dose finasteride administration for androgenic alopecia.
    Ryu HJ; Kwon DY
    Dermatol Surg; 2014 May; 40(5):595-7. PubMed ID: 24533595
    [No Abstract]   [Full Text] [Related]  

  • 4. Are hand preference and sexual orientation possible predicting factors for finasteride adverse effects in male androgenic alopecia?
    Motofei IG; Rowland DL; Georgescu SR; Tampa M; Baleanu BC; Paunica S
    Exp Dermatol; 2016 Jul; 25(7):557-8. PubMed ID: 26990657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical post-finasteride syndrome: A pharmacological riddle.
    Gupta AK; Sharma N; Shukla P
    Indian J Pharmacol; 2016; 48(3):316-7. PubMed ID: 27298504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia: A Meta-analysis.
    Belknap SM; Aslam I; Kiguradze T; Temps WH; Yarnold PR; Cashy J; Brannigan RE; Micali G; Nardone B; West DP
    JAMA Dermatol; 2015 Jun; 151(6):600-6. PubMed ID: 25830296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Finasteride-associated male infertility.
    Chiba K; Yamaguchi K; Li F; Ando M; Fujisawa M
    Fertil Steril; 2011 Apr; 95(5):1786.e9-11. PubMed ID: 21193189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Finasteride adverse effects in subjects with androgenic alopecia: A possible therapeutic approach according to the lateralization process of the brain.
    Motofei IG; Rowland DL; Georgescu SR; Tampa M; Baconi D; Stefanescu E; Baleanu BC; Balalau C; Constantin V; Paunica S
    J Dermatolog Treat; 2016 Nov; 27(6):495-497. PubMed ID: 27046152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study.
    Ali AK; Heran BS; Etminan M
    Pharmacotherapy; 2015 Jul; 35(7):687-95. PubMed ID: 26133534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis.
    Jang YH; Lee JY; Kang HY; Lee ES; Kim YC
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1312-6. PubMed ID: 20337826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased alcohol consumption among former male users of finasteride with persistent sexual side effects: a preliminary report.
    Irwig MS
    Alcohol Clin Exp Res; 2013 Nov; 37(11):1823-6. PubMed ID: 23763349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Finasteride and the Uncertainties of Establishing Harms.
    Moore TJ
    JAMA Dermatol; 2015 Jun; 151(6):585-6. PubMed ID: 25831198
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia.
    Sato A; Takeda A
    J Dermatol; 2012 Jan; 39(1):27-32. PubMed ID: 21980923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent sexual side effects of finasteride: could they be permanent?
    Canguven O; Talib RA
    J Sex Med; 2013 May; 10(5):1441. PubMed ID: 23421328
    [No Abstract]   [Full Text] [Related]  

  • 15. Post-finasteride syndrome.
    Pereira AFJR; Coelho TOA
    An Bras Dermatol; 2020; 95(3):271-277. PubMed ID: 32317131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finasteride-related Leydig cell tumour: report of a case and literature review.
    Berthold D; Lhermitte B; Uffer M; Doerfler A
    Andrologia; 2012 May; 44 Suppl 1():836-7. PubMed ID: 21950360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety Profile of Finasteride: Distribution of Adverse Effects According to Structural and Informational Dichotomies of the Mind/Brain.
    Motofei IG; Rowland DL; Manea M; Georgescu SR; Păunică I; Sinescu I
    Clin Drug Investig; 2017 Jun; 37(6):511-517. PubMed ID: 28161756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Finasteride and androgenic alopecia; from therapeutic options to medical implications.
    Motofei IG; Rowland DL; Tampa M; Sarbu MI; Mitran MI; Mitran CI; Stoian AP; Diaconu CC; Paunica S; Georgescu SR
    J Dermatolog Treat; 2020 Jun; 31(4):415-421. PubMed ID: 30897009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating 5 alpha reductase inhibitors for the treatment of male androgenic alopecia.
    Courtney A; Triwongwarant D; Chim I; Eisman S; Sinclair R
    Expert Opin Pharmacother; 2023; 24(18):1919-1922. PubMed ID: 37942878
    [No Abstract]   [Full Text] [Related]  

  • 20. Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects.
    Irwig MS
    J Clin Psychiatry; 2012 Sep; 73(9):1220-3. PubMed ID: 22939118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.